ID

16684

Description

HuMax-CD20 in Chronic Lymphocytic Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT00093314

Lien

https://clinicaltrials.gov/show/NCT00093314

Mots-clés

Versions (2)
  1. 31/07/2016 31/07/2016 -
  2. 01/08/2016 01/08/2016 -
Téléchargé le

1 août 2016

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Chronic Lymphocytic Leukemia NCT00093314

Anglais

Eligibility Chronic Lymphocytic Leukemia NCT00093314

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
chronic lymphocytic leukemia
Description

Chronic Lymphocytic Leukemia

Type de données

boolean

Alias
UMLS CUI [1]
C0023434
circulating lymphocytes above a specific level
Description

Increased number of circulating lymphocytes

Type de données

boolean

Alias
UMLS CUI [1]
C1849238
circulating lymphocytes showing certain markers
Description

Lymphocyte Circulating | Lymphocyte markers

Type de données

boolean

Alias
UMLS CUI [1,1]
C0024264
UMLS CUI [1,2]
C0175630
UMLS CUI [2]
C0023158
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
previous treatment with rituximab or alemtuzumab within 6 months prior to enrollment in study.
Description

rituximab | alemtuzumab

Type de données

boolean

Alias
UMLS CUI [1]
C0393022
UMLS CUI [2]
C0383429
previous stem cell transplantation.
Description

Stem cell transplant

Type de données

boolean

Alias
UMLS CUI [1]
C1504389
received any of the following treatments within 4 weeks prior to entering this trial: a) anti-cancer therapy, b) glucocorticoids unless less than 10 mg per day, c) radiotherapy.
Description

cancer treatment | Glucocorticoids | Therapeutic radiology procedure

Type de données

boolean

Alias
UMLS CUI [1]
C0920425
UMLS CUI [2]
C0017710
UMLS CUI [3]
C1522449
hiv positivity.
Description

HIV Seropositivity

Type de données

boolean

Alias
UMLS CUI [1]
C0019699
hepatitis b or hepatitis c.
Description

Hepatitis B | Hepatitis C

Type de données

boolean

Alias
UMLS CUI [1]
C0019163
UMLS CUI [2]
C0019196
other cancerous diseases, except certain skin cancers and cervix cancer.
Description

Malignant Neoplasms | Skin carcinoma | Cervix carcinoma

Type de données

boolean

Alias
UMLS CUI [1]
C0006826
UMLS CUI [2]
C0699893
UMLS CUI [3]
C0302592
certain serious medical conditions, including kidney or liver disease, some psychiatric illnesses, and stomach, heart, hormonal, nerve or blood diseases.
Description

medical condition Serious | Kidney Diseases | Liver diseases | Mental disorders | Stomach Diseases | Heart Diseases | Endocrine System Diseases | nervous system disorder | Hematological Disease

Type de données

boolean

Alias
UMLS CUI [1,1]
C3843040
UMLS CUI [1,2]
C0205404
UMLS CUI [2]
C0022658
UMLS CUI [3]
C0023895
UMLS CUI [4]
C0004936
UMLS CUI [5]
C0038354
UMLS CUI [6]
C0018799
UMLS CUI [7]
C0014130
UMLS CUI [8]
C0027765
UMLS CUI [9]
C0018939
participation in another trial with a different new drug 4 weeks prior to enrollment in study.
Description

Study Subject Participation Status | Investigational New Drug Different

Type de données

boolean

Alias
UMLS CUI [1]
C2348568
UMLS CUI [2,1]
C0013230
UMLS CUI [2,2]
C1705242
current participation in any other clinical study.
Description

Study Subject Participation Status

Type de données

boolean

Alias
UMLS CUI [1]
C2348568
pregnant or breast-feeding women.
Description

Pregnancy | Breast Feeding

Type de données

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
women of childbearing age who are unable or unwilling to use adequate contraception.
Description

Childbearing Potential Age | Contraceptive methods Unwilling

Type de données

boolean

Alias
UMLS CUI [1,1]
C3831118
UMLS CUI [1,2]
C0001779
UMLS CUI [2,1]
C0700589
UMLS CUI [2,2]
C0558080
Retour au début de la page

Similar models

Eligibility Chronic Lymphocytic Leukemia NCT00093314

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Chronic Lymphocytic Leukemia
Item
chronic lymphocytic leukemia
boolean
C0023434 (UMLS CUI [1])
Increased number of circulating lymphocytes
Item
circulating lymphocytes above a specific level
boolean
C1849238 (UMLS CUI [1])
Lymphocyte Circulating | Lymphocyte markers
Item
circulating lymphocytes showing certain markers
boolean
C0024264 (UMLS CUI [1,1])
C0175630 (UMLS CUI [1,2])
C0023158 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
rituximab | alemtuzumab
Item
previous treatment with rituximab or alemtuzumab within 6 months prior to enrollment in study.
boolean
C0393022 (UMLS CUI [1])
C0383429 (UMLS CUI [2])
Stem cell transplant
Item
previous stem cell transplantation.
boolean
C1504389 (UMLS CUI [1])
cancer treatment | Glucocorticoids | Therapeutic radiology procedure
Item
received any of the following treatments within 4 weeks prior to entering this trial: a) anti-cancer therapy, b) glucocorticoids unless less than 10 mg per day, c) radiotherapy.
boolean
C0920425 (UMLS CUI [1])
C0017710 (UMLS CUI [2])
C1522449 (UMLS CUI [3])
HIV Seropositivity
Item
hiv positivity.
boolean
C0019699 (UMLS CUI [1])
Hepatitis B | Hepatitis C
Item
hepatitis b or hepatitis c.
boolean
C0019163 (UMLS CUI [1])
C0019196 (UMLS CUI [2])
Malignant Neoplasms | Skin carcinoma | Cervix carcinoma
Item
other cancerous diseases, except certain skin cancers and cervix cancer.
boolean
C0006826 (UMLS CUI [1])
C0699893 (UMLS CUI [2])
C0302592 (UMLS CUI [3])
medical condition Serious | Kidney Diseases | Liver diseases | Mental disorders | Stomach Diseases | Heart Diseases | Endocrine System Diseases | nervous system disorder | Hematological Disease
Item
certain serious medical conditions, including kidney or liver disease, some psychiatric illnesses, and stomach, heart, hormonal, nerve or blood diseases.
boolean
C3843040 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
C0022658 (UMLS CUI [2])
C0023895 (UMLS CUI [3])
C0004936 (UMLS CUI [4])
C0038354 (UMLS CUI [5])
C0018799 (UMLS CUI [6])
C0014130 (UMLS CUI [7])
C0027765 (UMLS CUI [8])
C0018939 (UMLS CUI [9])
Study Subject Participation Status | Investigational New Drug Different
Item
participation in another trial with a different new drug 4 weeks prior to enrollment in study.
boolean
C2348568 (UMLS CUI [1])
C0013230 (UMLS CUI [2,1])
C1705242 (UMLS CUI [2,2])
Study Subject Participation Status
Item
current participation in any other clinical study.
boolean
C2348568 (UMLS CUI [1])
Pregnancy | Breast Feeding
Item
pregnant or breast-feeding women.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Childbearing Potential Age | Contraceptive methods Unwilling
Item
women of childbearing age who are unable or unwilling to use adequate contraception.
boolean
C3831118 (UMLS CUI [1,1])
C0001779 (UMLS CUI [1,2])
C0700589 (UMLS CUI [2,1])
C0558080 (UMLS CUI [2,2])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial